N. Wassilew, H. Hoffmann, C. Andrejak, and C. Lange, Pulmonary disease caused by non-tuberculous mycobacteria, Respiration, vol.91, pp.386-402, 2016.

T. R. Aksamit, J. V. Philley, and D. E. Griffith, Nontuberculous mycobacterial lung disease: the top ten essentials, Respir Med, vol.108, pp.417-442, 2014.

R. M. Raju, S. M. Raju, Y. Zhao, and E. J. Rubin, Leveraging advances in tuberculosis diagnosis and treatment to address nontuberculous mycobacterial disease, Emerg Infect Dis, vol.22, pp.365-374, 2016.

K. L. Winthrop, E. Mcnelley, and B. Kendall, Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease, Am J Respir Crit Care Med, vol.182, pp.977-82, 2010.

D. E. Griffith, T. Aksamit, B. A. Brown-elliott, A. Catanzaro, C. Daley et al., An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases, Am J Respir Crit Care Med, vol.175, pp.367-416, 2007.

C. S. Haworth, J. Banks, and T. Capstick, British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD), Thorax, vol.72, pp.1-64, 2017.

L. O. Larsson, E. Polverino, W. Hoefsloot, L. R. Codecasa, R. Diel et al., Pulmonary disease by nontuberculous mycobacteria-clinical management, unmet needs and future perspectives, Exp Rev Respir Med, vol.11, pp.977-89, 2017.

M. Kartalija, A. R. Ovrutsky, and C. L. Bryan, Patients with nontuberculous mycobacterial lung disease exhibit unique body and immune phenotypes, Am J Respir Crit Care Med, vol.187, pp.197-205, 2013.

T. M. Rawson, A. Abbara, and K. Kranzer, Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study, Respir Med, vol.120, pp.101-109, 2016.

J. Adjemian, D. R. Prevots, J. Gallagher, K. Heap, R. Gupta et al., Lack of adherence to evidence-based treatment guidelines for nontuberculous mycobacterial lung disease, Ann Am Thorac Soc, vol.11, pp.9-16, 2014.

A. El-zeenni, S. Chanoine, S. Recule, J. P. Stahl, M. Maurin et al., Are guidelines on the management of non-tuberculous mycobacteria lung infections respected and what are the consequences for patients? A French retrospective study from 2007 to, Eur J Clin Microbiol Infect Dis, vol.37, pp.233-273, 2014.

D. E. Griffith, B. A. Brown, P. Cegielski, D. T. Murphy, and R. J. Wallace, Early results (at 6 months) with intermittent clarithromycin including regimens for lung disease due to Mycobacterium avium complex, Clin Infect Dis, vol.30, pp.288-92, 2000.

B. H. Jeong, K. Jeon, and H. Y. Park, Intermittent antibiotic therapy for nodular bronchiectatic Mycobacterium avium complex lung disease, Am J Respir Crit Care Med, vol.191, pp.96-103, 2015.

J. Kunst, M. Wickremasinghe, A. Wells, and R. Wilson, Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis, Eur Respir J, vol.28, pp.352-359, 2006.

I. Hafeez, M. F. Muers, S. A. Murphy, E. G. Evans, R. C. Barton et al., Nontuberculous mycobacterial lung infection complicated by chronic necrotising pulmonary aspergillosis, Thorax, vol.55, pp.717-726, 2000.

Y. Kobashi, M. Fukuda, K. Yoshida, N. Miyashita, Y. Niki et al., Chronic necrotizing pulmonary aspergillosis as a complication of pulmonary Mycobacterium avium complex disease, Respirology, vol.11, pp.809-822, 2006.

D. W. Denning, J. Cadranel, C. Beigelman-aubry, F. Ader, A. Chakrabarti et al., Chronic pulmonary aspergillosisrationale and clinical guidelines for diagnosis and management, Eur Resp J, vol.47, issue.1, pp.45-68, 2016.

J. Van-ingen, T. Aksamit, and C. Andrejak, Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement, Eur Respir J, vol.51, p.1800170, 2018.